Keywords: nippon, shinyaku, licenses, japanese, rights, lilly, tadalafil

Nippon Shinyaku licenses Japanese rights to Lilly

Article | 16 April 2009

Print This

Japanese mid-sized drugmaker Nippon Shinyaku has agreed to develop in its home market US drug major Eli Lilly's erectile dysfunction ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in